Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum.
Cell Rep Med. 2024 Apr 9:101516. doi: 10.1016/j.xcrm.2024.101516. Online ahead of print.
Cell Rep Med. 2024.
PMID: 38626769
Free article.
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials.
Ingels J, De Cock L, Mayer RL, Devreker P, Weening K, Heyns K, Lootens N, De Smet S, Brusseel M, De Munter S, Pille M, Billiet L, Goetgeluk G, Bonte S, Jansen H, Lint SV, Leclercq G, Taghon T, Menten B, Vermaelen K, Impens F, Vandekerckhove B.
Ingels J, et al. Among authors: devreker p.
Cytotherapy. 2022 Feb;24(2):213-222. doi: 10.1016/j.jcyt.2021.08.005. Epub 2021 Oct 22.
Cytotherapy. 2022.
PMID: 34696961
Free article.
Item in Clipboard
An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E, Heyns K, De Smet S, Devreker P, Ingels J, De Cabooter N, Debacker V, Dullaers M, VAN Meerbeeck JP, Vandekerckhove B, Vermaelen KY.
Brabants E, et al. Among authors: devreker p.
Cytotherapy. 2018 Sep;20(9):1164-1181. doi: 10.1016/j.jcyt.2018.06.006. Epub 2018 Aug 16.
Cytotherapy. 2018.
PMID: 30122654
Item in Clipboard
Cite
Cite